Learn more about Peter Attia’s digital program
Peter’s approach to managing patients with high Lp(a)
This video is a clip from episode #210 – Lp(a) and its impact on heart disease with Benoît Arsenault, Ph.D.,…
#210 – Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.
“I think we should advise people to measure Lp(a); that would be a gigantic step.” —Benoît Arsenault
For triglycerides, “normal” may not be “optimal”
How do triglyceride levels relate to cardiovascular risk?
Peter on the four horsemen of chronic disease
This audio clip is from AMA #14: What lab tests can (and cannot) inform us about our overall objective of…
#203 – AMA #34: What Causes Heart Disease?
“Not everybody dies from atherosclerosis, but… everybody dies with it.” — Peter Attia
When CAC Tests Are Useful and When They Are Not
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we…
Peter on why early prevention of atherosclerosis is critical
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we…
Preventing Atherosclerosis: 2 Fatal Flaws with the “10 Year Risk” Approach
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way…
#196 – AMA #32: Exercise, squats, deadlifts, BFR, and TRT
“You have to differentiate between signal and noise. . .it’s easy to say testosterone causes heart disease just like it’s easy to say estrogen causes breast cancer. But if you’re actually going to go through all of the data. . .I think it becomes very difficult to make that case.” —Peter Attia
Low LDL cholesterol and neural development
Why LDL-lowering treatments don’t pit head against heart